Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,108.50    25.50 (2.35%)
Bid:
1,113.50
Ask:
1,114.00
Spread: 0.50 (0.045%)
Market Cap: £3.98b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Director/PDMR Shareholding

26 Jun 2017 17:21

RNS Number : 2097J
Burberry Group PLC
26 June 2017
 

Burberry Group plc (the "Company") - Director/PDMR Shareholdings

 

The Company announces that on 26 June 2017 Julie Brown, a director of the Company, decided to waive 75% (94,860 shares) of the Executive Share Plan award she was granted on 30 January 2017 ("ESP 2016/17") due to the overlap of the 2016/17 performance period and 47,099 of nil cost options she was granted on 30 January 2017 (the "buy-out award") in the light of the vesting outcome of her 2014 award from her former employer. The Remuneration Committee welcomed and agreed with her decision.

 

The surrender caused the ESP 2016/17 nil-cost options to immediately lapse in respect of 94,860 shares. Julie continues to hold nil-cost options over the balance, being 31,620 shares under the ESP 2016/17.

 

Additionally, the surrender caused the buy-out award nil-cost options to immediately lapse in respect of 47,099 shares. Julie continues to hold nil-cost options over the balance, being 167,901 shares, which will vest (subject to continued employment) as follows:

 

· On 22 July 2017 - 38,901 shares;

· On 22 July 2018 - 64,500 shares;

· On 22 July 2019 - 64,500 shares.

The Company has also today disclosed on its website (www.burberryplc.com) within the Corporate Governance section) additional information relating to the assessment of performance for 2016/17 in respect of Christopher Bailey's 2014 Exceptional Performance-Based Award.

26 June 2017

The following disclosures are made in accordance with Article 19.3 of the EU Market Abuse Regulation 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Julie Brown

2

Reason for the notification

a)

Position/status

Chief Operating and Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each

 

 

GB0031743007

b)

Nature of the transaction

Surrender (for nil consideration) of nil-cost options over:

(i) 94,860 shares that were granted on 30 January 2017 under the Executive Share Plan; and

(ii) 47,099 shares that were granted on 30 January 2017 as compensation for the incentives Julie Brown forfeited on leaving her previous employer.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

94,860

Nil

47,099

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

Nil

141,959

Nil

e)

Date of the transaction

2017-06-26

 

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFLRRAIRFID
Date   Source Headline
3rd Dec 20184:10 pmRNSTotal Voting Rights
12th Nov 20183:00 pmRNSTreasury Shares Cancellation
8th Nov 201810:00 amRNSBoard Committee Changes
8th Nov 20187:00 amRNSHalf-year Report
25th Oct 20189:46 amRNSDirector Declaration
1st Oct 20181:32 pmRNSTotal Voting Rights
21st Sep 20183:29 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSTransaction in Own Shares
19th Sep 20187:00 amRNSTransaction in Own Shares
18th Sep 20187:00 amRNSTransaction in Own Shares
17th Sep 20187:00 amRNSTransaction in Own Shares
14th Sep 20187:00 amRNSTransaction in Own Shares
13th Sep 20187:00 amRNSTransaction in Own Shares
12th Sep 20187:00 amRNSTransaction in Own Shares
11th Sep 20187:00 amRNSTransaction in Own Shares
10th Sep 20187:00 amRNSTransaction in Own Shares
7th Sep 20187:00 amRNSTransaction in Own Shares
6th Sep 20187:00 amRNSTransaction in Own Shares
5th Sep 20187:00 amRNSTransaction in Own Shares
4th Sep 20187:00 amRNSTransaction in Own Shares
3rd Sep 20181:27 pmRNSBlock listing Interim Review
3rd Sep 20181:19 pmRNSTotal Voting Rights
3rd Sep 20187:00 amRNSTransaction in Own Shares
31st Aug 20187:00 amRNSTransaction in Own Shares
29th Aug 20187:00 amRNSTransaction in Own Shares
28th Aug 20187:00 amRNSTransaction in Own Shares
24th Aug 20187:00 amRNSTransaction in Own Shares
23rd Aug 20187:00 amRNSTransaction in Own Shares
22nd Aug 20187:00 amRNSTransaction in Own Shares
21st Aug 20187:00 amRNSTransaction in Own Shares
20th Aug 20187:00 amRNSTransaction in Own Shares
17th Aug 20187:00 amRNSTransaction in Own Shares
16th Aug 20187:00 amRNSTransaction in Own Shares
15th Aug 20187:00 amRNSTransaction in Own Shares
14th Aug 20187:00 amRNSTransaction in Own Shares
13th Aug 20187:00 amRNSTransaction in Own Shares
10th Aug 20187:00 amRNSTransaction in Own Shares
9th Aug 20187:00 amRNSTransaction in Own Shares
8th Aug 20187:00 amRNSTransaction in Own Shares
7th Aug 20187:00 amRNSTransaction in Own Shares
6th Aug 20183:46 pmRNSDirector/PDMR Shareholding
6th Aug 20187:00 amRNSTransaction in Own Shares
3rd Aug 20187:00 amRNSTransaction in Own Shares
2nd Aug 20187:00 amRNSTransaction in Own Shares
1st Aug 20183:30 pmRNSDirector/PDMR Shareholding
1st Aug 201812:27 pmRNSTotal Voting Rights
1st Aug 20187:00 amRNSTransaction in Own Shares
31st Jul 20187:00 amRNSTransaction in Own Shares
30th Jul 20187:00 amRNSTransaction in Own Shares
27th Jul 20187:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.